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Table 1
Group Counts in Samples of Pedigrees Multiplex for SLE and
Containing an Affected Member with Nephritis
NO. IN
Sample 1 Sample 2
Samples
1 and 2
Combined
GROUP AA EA AA EA AA EA
Pedigrees 40 31 27 43 67 74
Individuals affected with:
SLE 93 83 57 92 150 175
SLE and nephritis 61 46 37 54 98 100
Sib pairs 98 107 55 136 153 243
Concordant affected sib pairs 21 42 15 23 36 65
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SLEN2 (2q34–35) and SLEN1 (10q22.3) Replication in
Systemic Lupus Erythematosus Stratiﬁed by Nephritis
To the Editor:
Systemic lupus erythematosus (SLE) is a chronic, some-
times life threatening, systemic autoimmune disease. Af-
rican Americans (AA) have a 2–4 times higher incidence
of SLE, a higher rate of SLE nephritis, and a less fa-
vorable prognosis than European Americans (EA) (Petri
1998). Renal disease occurs in 40%–75% of patients
with SLE, within 5 years of disease onset (Garcı´a et al.
1996), contributing signiﬁcantly to the diseasemorbidity
and mortality rates of these patients. Patients with focal
and diffuse proliferative glomerulonephritis, as de-
scribed in the World Health Organization’s classiﬁcation
of SLE nephritis, have a clearly increased risk of devel-
oping severe renal impairment (Clark 1994).
Conﬁrmation of genetic linkage effects has become a
major impediment to progress in elucidating complex
genetic disorders. Explanations include false-positive re-
ports of linkage and uncertainty that originates from the
unknown complexity of the overall genetic heterogeneity
in the sampled populations. In addition, when genetic
effects are modest in magnitude across the sample and
are dependent on variables, such as ethnicity, replication
may require very large samples before conﬁdent conclu-
sions are possible.
Proposed standards for robust genetic linkages suggest
that signiﬁcance of the original linkage effect be at
the level for any linkage in a genome scanP ! .05
( ) and that the effect at replication achieveLOD ∼ 3.3
a sufﬁciently unlikely probability ( orP ! .05 LOD 
) for the original location (Lander and Kruglyak1. 2
1995). Consequently, replication studies (either studies
of a subsequent sample collected by the same investi-
gator or studies by an independent group of investiga-
tors) or a combined data analysis can help distinguish
the more robust ﬁndings from the false positives, as was
done in this study.
We sought to replicate ﬁndings, reported elsewhere
(Quintero-Del-Rio et al. 2002), of genetic linkage at
10q22.3 (SLEN1 [MIM 607965]) and 2q34–35 (SLEN2
[MIM 607966]), in 70 pedigrees with SLE nephritis
(pedigrees multiplex for SLE that contain at least one
individual with SLE who is also affected with lupus ne-
phritis). An independently collected sample of 71 ped-
igrees with SLE nephritis is now available to reapply the
nonparametric analysis of sibship allele sharing by the
Haseman and Elston algorithm (S.A.G.E. SIBPAL). A
total of 307 microsatellite markers were typed from
the Weber Screening Set version 8, with an average
marker spacing of 11 cM and an average heterozygosity
of 76.8% (SD of6%; range 60%–94%). Of the total
304 multiplex pedigrees available from the Oklahoma
lupus genetics collection (see Lupus Multiplex Registry
and Repository Web site), 164 multiplex pedigrees—
of which 141 were AA or EA pedigrees—contained at
least one member affected with SLE and nephritis.
Sample 1, published elsewhere (Quintero-Del-Rio et
al. 2002), contained 205 sib pairs (98 AA and 107 EA)
from 71 pedigrees with SLE nephritis (table 1). Sample
2, the replication sample reported here, contains 191 sib
pairs (55 AA and 136 EA) from 70 pedigrees with SLE
nephritis (table 1). A total of 396 sib pairs (153 AA and
243 EA) from 141 pedigrees with SLE nephritis were
available for the combined analysis.
Of the 325 individuals affected with SLEwho are from
these 141 pedigrees with SLE nephritis, lupus nephritis
was ascertained in 238 (103 [32%] with proteinuria, 18
[5.5%] with cellular casts, and 117 [36%] with both),
with a similar distribution of proteinuria and cellular
casts between the two samples.
The original linkage scan of 71 pedigrees with SLE
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Figure 1 Linkage observed in pedigrees multiplex for SLE and stratiﬁed by race and lupus nephritis. A, Effect at 2q34–35 in African
American pedigrees. B, Results at 10q22.3 in European American pedigrees. S.A.G.E. SIBPAL was used for the analysis. Centimorgans are
plotted on the X-axis, and P values are plotted on the Y-axis. The dotted lines represent the published results of sample 1 at 2q34–35 and
10q22.3 (Quintero-Del-Rio et al. 2002), whereas the dashed lines represent the conﬁrmation group (sample 2) ﬁndings, and the solid line
represents the combined effect from both samples.
nephritis (Quintero-Del-Rio et al. 2002) produced a
linkage effect ( ) between D2S1384 andPp .00002
D2S434 at 2q34–35 (SLEN2) in the AA pedigrees (ﬁg.
1A). This effect was sufﬁcient to establish linkage
(Lander and Kruglyak 1995). The 27 AA pedigrees of
sample 2 produced a linkage effect ( ) at thePp .002
same position between D2S1384 and D2S434 at 2q34–
35, which is more than sufﬁcient to conﬁrm SLEN2 link-
age (ﬁg. 1A). The combination of samples produces a
high probability of linkage at this location (.9999994)
and a low probability that the observed relationship is
a random ﬁnding ( ).Pp .0000006
The original linkage scan on pedigrees with SLE ne-
phritis (Quintero-Del-Rio et al. 2002) produced a Pp
with D10S2470 at 10q22.3 (SLEN1) in the.00000015
EA pedigrees (ﬁg. 1B). The conﬁrmatory set of 43 EA
pedigrees with SLE nephritis resulted in be-Pp .001
tween D10S1432 and D10S2327 on chromosome 10.
This region is 14 cM centromeric to the maximum area
of linkage in sample 1 (ﬁg. 1B). Both independent sam-
ples of pedigrees resulted in a combined Pp .00001
between D10S2327 and D10S2470.
The interpretation for SLEN1 is less straightforward
than it is for SLEN2. The magnitude of the linkage effect
is sufﬁcient to conﬁrm linkage, but not at the original
location. Overall, the linkage effect is diminished, but it
is sufﬁciently robust to remain established. The issue of
whether this linkage is conﬁrmed may be controversial,
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and, therefore, more data is desirable, as with most com-
plex human genetic effects.
The average contribution to the maximum linkage ef-
fect at SLEN2 from sample 2 (55 sibships; ) isPp .002
very similar to that from sample 1 (98 sibships; Pp
): 0.046 and 0.048 log units of P1 per sibship,.00002
respectively. This level of consistent independent con-
tribution between samples is unusual among complex
genetic diseases.
SLEN2 is syntenic to bxs1 (sle7) in the BXSB murine
model of SLE, located at 32.8 cM on mouse chromo-
some 1. Similar to SLEN2, bxs1 may make a contri-
bution to lupus nephritis (see Mouse Genome Infor-
matics and NCBI GenBank Web sites).
The sample 2 results, through successful replication,
and the combined data analysis of the large study sample
provide powerful evidence supporting an SLE suscep-
tibility locus at 2q34–35 and provide additional evidence
supporting linkage at 10q22.
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